Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

While politicos dispense blame, these doctors aim to take shame out of medicine

The distress that Will Bynum later recognized as shame settled over him nearly immediately.

5 Nov 2025

AI helps detect early signs of alcoholism in firefighters with 80% accuracy

A deep learning model using brain scans and tests predicts alcohol use disorder risk in firefighters, enhancing mental health strategies in high-stress jobs.

5 Nov 2025

PRIME fiber-optic device can manipulate neural activity deep in the brain

Fiber-optic technology revolutionized the telecommunications industry and may soon do the same for brain research.

4 Nov 2025

Survival patterns differ across types of early-onset dementia

The survival rates of people with early onset dementia-diagnosed before the age of 65-vary considerably by clinical type, but sex, age, family history and co-existing conditions aren't specific risk factors, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

4 Nov 2025

Three health tech innovators push boundaries to build a brighter future of cardiovascular care

As digital health technologies gain momentum, research is finding that more people are open to artificial intelligence (AI) supported health interventions when those are backed by clinical expertise and rooted in evidence-based guidelines.

4 Nov 2025

Stress hormones may silence crucial neuronal genes through specific RNA molecules

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes deep inside chromatin? Researchers at the University of Alabama at Birmingham have now shown that stress hormones may silence crucial neuronal genes through an unexpected class of RNA molecules that operate not by encoding proteins, but by reshaping the genome's architecture.

4 Nov 2025

New WashU center aims to transform disease diagnosis through AI imaging

Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis is establishing a new center dedicated to developing AI-based imaging tools to improve the diagnosis and precision treatment of cancers, cardiovascular disease, neurological diseases and numerous other conditions.

3 Nov 2025

Johns Hopkins study reveals enzyme that shields neurons from oxidative stress

New research from Johns Hopkins Medicine shows that the enzyme biliverdin reductase A (BVRA) plays a direct protective role against oxidative stress in neurons, independent of its role producing the yellow pigment bilirubin.

3 Nov 2025

International experts urge the reclassification of postpartum psychosis to improve treatment

An international panel of leading women's mental health experts – including UVA Health's Jennifer Payne, MD – is calling to reclassify postpartum psychosis as its own category of mental illness to improve the care new mothers receive.

3 Nov 2025

New $4.4 million grant funds first study of prefrontal cortical stimulation in severe bipolar disorder

A University of Minnesota Medical School research team, led by Ziad Nahas, MD, has been awarded a $4.4 million grant for a first-in-the-world study of prefrontal cortical stimulation in severe bipolar disorder.

31 Oct 2025

COVID-19 in pregnancy may raise autism and neurodevelopmental disorder risk

Children born to mothers who contracted COVID-19 during pregnancy face a 29% higher likelihood of developmental disorders by age three, including speech, motor, and autism-spectrum delays. The risk was greatest for male offspring and infections occurring in the third trimester.

30 Oct 2025

Study uncovers neural mechanisms behind memory stabilization

Newly decoded brain circuits make memories more stable as part of learning, according to a new study led by NYU Langone Health researchers.

30 Oct 2025

Liver alterations associated with MASLD can directly affect the brain and behavior

A multidisciplinary research team has discovered that liver alterations associated with metabolic dysfunction-associated fatty liver disease (MASLD) can directly cause cognitive and neurological impairments, and that these effects can be reversed by a therapy exclusively targeting the liver.

30 Oct 2025

Dance alleviates perceived symptoms of depression, study finds

Dance as a performative art form alleviates perceived symptoms of depression, helps to understand its root causes and promotes self-actualization, a recent study from the University of Eastern Finland found.

30 Oct 2025

Sertraline contributes to a modest improvement in core depression and anxiety symptoms

One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major clinical trial led by UCL researchers.

30 Oct 2025

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

A systematic review published today in Psychedelics by Mr. James Gattuso and colleagues at the Florey Institute of Neuroscience and Mental Health synthesizes clinical and preclinical evidence on psilocybin's effects on obsessive-compulsive behaviors, revealing consistent therapeutic potential across human patients and validated animal models.

29 Oct 2025

Emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder

In a peer-reviewed article published today in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder (OCD).

28 Oct 2025

Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar disorder and pioneer novel neuromodulation-based treatment strategies.

28 Oct 2025

New BRIGHT Center aims to build resilience after trauma

The Medical University of South Carolina has been awarded more than $11 million by the National Institute of General Medical Sciences over five years to establish a Center of Biomedical Research Excellence (COBRE) to build resilience after trauma, which will be known as the South Carolina Building Resilience through Innovative Interventions to promote Growth and Health after Trauma COBRE, or the BRIGHT Center.

24 Oct 2025

Psilocybin and mindfulness offer new hope for depressive healthcare workers

Frontline healthcare workers struggling with depression after the COVID-19 pandemic experienced significant relief from a treatment combining psilocybin group therapy with mindfulness training, according to a new study from Huntsman Mental Health Institute at University of Utah Health.

23 Oct 2025

Psychiatry News and Research

Further Reading

While politicos dispense blame, these doctors aim to take shame out of medicine

AI helps detect early signs of alcoholism in firefighters with 80% accuracy

PRIME fiber-optic device can manipulate neural activity deep in the brain

Survival patterns differ across types of early-onset dementia

Three health tech innovators push boundaries to build a brighter future of cardiovascular care

Stress hormones may silence crucial neuronal genes through specific RNA molecules

New WashU center aims to transform disease diagnosis through AI imaging

Johns Hopkins study reveals enzyme that shields neurons from oxidative stress

International experts urge the reclassification of postpartum psychosis to improve treatment

New $4.4 million grant funds first study of prefrontal cortical stimulation in severe bipolar disorder

COVID-19 in pregnancy may raise autism and neurodevelopmental disorder risk

Study uncovers neural mechanisms behind memory stabilization

Liver alterations associated with MASLD can directly affect the brain and behavior

Dance alleviates perceived symptoms of depression, study finds

Sertraline contributes to a modest improvement in core depression and anxiety symptoms

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

Emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder

Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder

New BRIGHT Center aims to build resilience after trauma

Psilocybin and mindfulness offer new hope for depressive healthcare workers

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News